| Trial ID: | L0952 |
| Source ID: | IRCT201102235893N1
|
| Associated Drug: |
L-carnitine
|
| Title: |
The L-carnitine effect in the treatment of non alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention 1: IN intervention group: 500mg L- carnitine, two times a day, as well as recommendation for exercise, weight loss and low fat diet, for six months. Intervention 2: Contol group: recommendations for exercise, weight loss, and low fat diet for
|
| Outcome Measures: |
Serum level of alanine aminotransferase. Timepoint: Before intervention and six months after initiation of the intervention. Method of measurement: measuring serum level.Serum level of aspartate aminotransferase. Timepoint: Before intervention and six months after initiation of the intervention. Method of measurement: by serum level measurement.;Fatty liver grading. Timepoint: befor intervention and six months after initiation intervention. Method of measurement: by ultasonography.
|
| Sponsor/Collaborators: |
Gasrtoenterology Research Centre Of Imam Reza Hospital
|
| Gender: |
All
|
| Age: |
14 yearsno limit
|
| Phases: |
Not applicable
|
| Enrollment: |
80
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
30/07/2011
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/6368
|
